IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo

Tania Pilli,Silvia Cantara,Lutz Schomburg,Valeria Cenci,Sandro Cardinale,Ellen C.D. Heid,Eike C. Kühn,Gabriele Cevenini,Fausta Sestini,Carla Fioravanti,Gabriele DHauw,Furio Pacini

IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo

2015

Tania Pilli
Silvia Cantara
Lutz Schomburg
Valeria Cenci
Sandro Cardinale
Ellen C.D. Heid
Eike C. Kühn
Gabriele Cevenini
Fausta Sestini
Carla Fioravanti
Gabriele DHauw
Furio Pacini

Background: Several studies have suggested that selenium may influence the natural history of autoimmune thyroiditis (AIT). Recently, IFNγ-inducible chemokin

Keywords:

Placebo
Euthyroid
Thyroiditis
Chemokine
Internal medicine
Diabetes mellitus
Autoimmune thyroiditis
Selenium
Endocrinology
Natural history
Medicine
Immunology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations